Clinical genetics in breast cancer
- PMID: 38557982
- PMCID: PMC11246818
- DOI: 10.1002/jso.27630
Clinical genetics in breast cancer
Abstract
As genetic testing becomes increasingly more accessible and more applicable with a broader range of clinical implications, it may also become more challenging for breast cancer providers to remain up-to-date. This review outlines some of the current clinical guidelines and recent literature surrounding germline genetic testing, as well as genomic testing, in the screening, prevention, diagnosis, and treatment of breast cancer, while identifying potential areas of further research.
Keywords: breast cancer; genetic testing; genomic testing; hereditary; patient outcomes.
© 2024 Wiley Periodicals LLC.
References
-
- Surveillance E, & End Results (SEER) Program. SEER*Stat Database: Incidence—SEER Research Data, 17 Registries, November 2021 Submission (2000–2019)—Linked To County Attributes—Time Dependent (1990–2019) Income/Rurality, 1969–2020 Counties. Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute. 2022.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials